AR is activated after the binding of androgenic ligands and has a pivotal role in prostate cancer development.9, 10 AR has become the most crucial therapeutic target in prostate cancer treatment.11, 12, 13 However, many treatments targeting AR signaling are noncurative and associated with a poor prognosis, despite continuous hormonal manipulation. This evidence concerns the gene AR and prostate carcinoma.